These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26480992)

  • 21. Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis.
    Schmohl M; Gansser D; Moschetti V; Stangier J
    Thromb Res; 2015 Mar; 135(3):532-6. PubMed ID: 25600440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory assessment of haemostatic parameters in patients taking a direct thrombin inhibitor].
    Beliavskaia OO; Vavilova TV
    Angiol Sosud Khir; 2014; 20(4):37-41. PubMed ID: 25490355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.
    Pollack CV; Reilly PA; Bernstein R; Dubiel R; Eikelboom J; Glund S; Huisman MV; Hylek E; Kam CW; Kamphuisen PW; Kreuzer J; Levy JH; Sellke F; Stangier J; Steiner T; Wang B; Weitz JI
    Thromb Haemost; 2015 Jul; 114(1):198-205. PubMed ID: 26020620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Images in emergency medicine. Activated charcoal aspiration.
    Hack JB; Gilliland MG; Meggs WJ
    Ann Emerg Med; 2006 Nov; 48(5):522, 531. PubMed ID: 17052551
    [No Abstract]   [Full Text] [Related]  

  • 25. Zopiclone overdose responsive to flumazenil.
    Cienki JJ; Burkhart KK; Donovan JW
    Clin Toxicol (Phila); 2005; 43(5):385-6. PubMed ID: 16235515
    [No Abstract]   [Full Text] [Related]  

  • 26. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A; Baranchuk A; Redfearn D; Simpson C; Abdollah H; Michael K
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):529-40. PubMed ID: 25843430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
    Gessoni G; Valverde S; Gessoni F; Valle R
    Blood Transfus; 2015 Oct; 13(4):666-8. PubMed ID: 25761318
    [No Abstract]   [Full Text] [Related]  

  • 28. [Time limits for gastrointestinal decontamination in poisoning].
    von Westphal V; Jacobsen P
    Ugeskr Laeger; 2009 Feb; 171(9):718. PubMed ID: 19258001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy Volunteers.
    Glund S; Stangier J; van Ryn J; Schmohl M; Moschetti V; Haazen W; De Smet M; Gansser D; Norris S; Lang B; Reilly P; Kreuzer J
    J Am Coll Cardiol; 2016 Apr; 67(13):1654-1656. PubMed ID: 27150693
    [No Abstract]   [Full Text] [Related]  

  • 30. Idarucizumab for dabigatran overdose.
    Peetermans M; Pollack C; Reilly P; Liesenborghs L; Jacquemin M; Levy JH; Weitz JI; Verhamme P
    Clin Toxicol (Phila); 2016 Sep; 54(8):644-6. PubMed ID: 27224445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations.
    Božič-Mijovski M; Malmström RE; Malovrh P; Antovic JP; Vene N; Šinigoj P; Mavri A
    Ann Clin Biochem; 2016 Jul; 53(Pt 4):446-51. PubMed ID: 26392631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dabigatran: a cause of hematologic emergency.
    Lal Y; Van Heukelom J
    Am J Med Sci; 2013 Sep; 346(3):190-3. PubMed ID: 23221509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In response to "Conservative Management of Intentional Massive Dabigatran Overdose".
    Cantrell FL
    J Am Geriatr Soc; 2016 May; 64(5):1147. PubMed ID: 27225374
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
    Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated charcoal adsorbs colchicine but does not replace gastric lavage.
    Prescrire Int; 2011 Feb; 20(113):54. PubMed ID: 21491672
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples.
    Hapgood G; Butler J; Malan E; Chunilal S; Tran H
    Thromb Haemost; 2013 Aug; 110(2):308-15. PubMed ID: 23783268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated Charcoal RCT.
    Cooper GM; Buckley NA
    Am J Ther; 2003; 10(3):235-6. PubMed ID: 12756436
    [No Abstract]   [Full Text] [Related]  

  • 38. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.
    Kaatz S; Kouides PA; Garcia DA; Spyropolous AC; Crowther M; Douketis JD; Chan AK; James A; Moll S; Ortel TL; Van Cott EM; Ansell J
    Am J Hematol; 2012 May; 87 Suppl 1():S141-5. PubMed ID: 22473649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Slow-release overdose.
    Shenfield GM
    Med J Aust; 1993 Feb; 158(3):150-1. PubMed ID: 8450776
    [No Abstract]   [Full Text] [Related]  

  • 40. Dabigatran: life-threatening bleeding.
    Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.